Navigation Links
The 3 percent solution: Unpopular drug companies still push discovery

Madison, Wis. - John McNeish gives it a light-hearted spin when he talks about drug companies being one of the least trusted institutions in America.

"The polls say only 3 percent of the people in the country have a favorable view of drug companies," Pfizer executive McNeish told a group of about 75 people, mostly scientists, who gathered at Universit......

Full article >>> al for drug discovery," McNeish said.

While Pfizer has worked with mouse stem cells, it has not conducted experiments involving human stem cells. While McNeish and his colleagues see tremendous potential in working with such cells, they also see many financial and public policy risks.

The costs of bringing a drug to market are enormous, not counting the ads. Pfizer may unveil a c......

Full article >>> ncil and the Wisconsin Innovation Network. He is the former associate editor of the Wisconsin State Journal in Madison.

The opinions expressed herein or statements made in the above column are solely those of the author, and do not necessarily reflect the views of Wisconsin Technology Network, LLC. (WTN). WTN, LLC accepts no legal liability or responsibility for any claims made or op......

Full article >>>
'"/> By Tom Still 09/12/05

Related biology technology :

1. National angel investment grew 11 percent in `06
2. Musicnotes reports 45 percent growth in 2006
3. Fiserv posts 30 percent quarterly loss
4. RedPrairie exec calls for 50 percent tax cut
5. Renaissance earnings down 46 percent
6. GE Healthcare third-quarter profits up 17 percent
7. Criticare reports 20.3 percent increase in sales
8. Rockwell Automation ups quarterly dividend by 36 percent
9. Its 99 percent certain: Research cannot rely on adult stem cells alone
10. A disgusting video: U.S. companies sell out Americans
11. Pre-eminent, web-based companies owe success to corporate venturing
Post Your Comments:

(Date:11/24/2015)... , November 24, 2015 ... new market research report "Oligonucleotide Synthesis Market by Product ... (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical ... published by MarketsandMarkets, the market is expected to reach ... in 2015, at a CAGR of 10.1% during the ...
(Date:11/24/2015)... SHPG ) announced today that Jeff Poulton , Chief ... Annual Healthcare Conference in New York City , ... p.m. GMT). --> SHPG ) announced today that ... Jaffray 27 th Annual Healthcare Conference in New ... 8:30 a.m. EST (1:30 p.m. GMT). --> Shire plc ...
(Date:11/24/2015)... CITY , Nov. 24, 2015 /PRNewswire/ - ... "Company") announced today that the remaining 11,000 post-share ... Share Purchase Warrants (the "Series B Warrants") subject ... were exercised on November 23, 2015, which will ... Shares.  After giving effect to the issuance of ...
(Date:11/24/2015)... ... November 24, 2015 , ... InSphero AG, the leading supplier of easy-to-use solutions ... Melanie Aregger to serve as Chief Operating Officer. , Having joined InSphero ... team and was promoted to Head of InSphero Diagnostics in 2014. There ...
Breaking Biology Technology:
(Date:11/10/2015)... Nov. 10, 2015  In this report, ... basis of product, type, application, disease indication, ... this report are consumables, services, software. The ... safety biomarkers, efficacy biomarkers, and validation biomarkers. ... are diagnostics development, drug discovery and development, ...
(Date:11/9/2015)... , Nov. 9, 2015  Synaptics Inc. (NASDAQ: ... today announced broader entry into the automotive market with ... match the pace of consumer electronics human interface innovation. ... are ideal for the automotive industry and will be ... Europe , Japan ...
(Date:10/29/2015)... Minn. , Oct. 29, 2015   MedNet ... supports the entire spectrum of clinical research, is pleased ... Minnesota High Tech Association (MHTA) as one of only ... in the "Software – Small and Growing" category. The Tekne ... individuals who have shown superior technology innovation and leadership. ...
Breaking Biology News(10 mins):